https://www.businesswire.com/news/home/20251110761345/en/Belenos-Pipeline-Updates-First-Clinical-Data-from-Lead-Asset-BEL512-a-Long-lasting-Bispecific-Targeting-TSLP-and-IL-13-Second-Asset-BEL536-a-First-in-class-Long-acting-Bispecific-Targeting-OX40L-and-IL-13-Phase-1-to-Start-1Q2026
Belenos Biosciences Inc.: BEL512: Support for Extended Dosing Intervals: Subcutaneous BEL512 (CM512) demonstrated long half-life of up to 70 days Clinical Im...
clinical databelenospipelineupdatesfirst
https://www.newsfilecorp.com/release/269536/Biotech-and-Medical-Tech-Stocks-Report-Breakthrough-Clinical-Trial-Updates
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - October 8, 2025) - Investorideas.com, a go-to investing platform covering biotech and...
clinical trial updatesmedical techbiotechstocksreport
https://www.fhea.com/np-continuing-education/np-webinars/
Elevate your NP career with our FREE webinars designed for professional growth, featuring engaging sessions with an expert NP and interactive Q&A...
webinars liveclinical updatesfreenpamp
https://www.businesswire.com/news/home/20220930005139/en/Rocket-Pharmaceuticals-Announces-Positive-Updates-from-Phase-1-Clinical-Trial-for-RP-A501-in-Danon-Disease-at-the-Heart-Failure-Society-of-America-HFSA-Annual-Scientific-Meeting-2022
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of investigational g...
clinical trialrocketpharmaceuticalsannouncespositive
https://www.digitaljournal.com/pr/news/geographic-atrophy-emerging-and-marketed-drugs-assessment-2023-updates-clinical-and-non-clinical-trials-evaluation-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies
geographic atrophyemergingmarketeddrugsassessment
https://www.digitaljournal.com/pr/news/eczema-emerging-and-marketed-drugs-assessment-2023-updates-clinical-and-non-clinical-trials-evaluation-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies
eczemaemergingmarketeddrugsassessment
https://www.cincinnatichildrens.org/service/m/mayerson-center/hcp/clinical/abuse/visual
Find information on case reports and studies discussing the visual outcomes for children diagnosed with shaken baby syndrome.
clinical updatesvisualoutcomescenter
https://www.digitaljournal.com/pr/news/neuroendocrine-tumors-emerging-and-marketed-drugs-assessment-2023-updates-clinical-and-non-clinical-trials-evaluation-latest-fda-ema-and-pmda-approvals-treatment-outlook-competitive-landscape-and-key-companies
neuroendocrine tumorsemergingmarketeddrugsassessment
https://pubmed.ncbi.nlm.nih.gov/36563781/
The drug allergy practice parameter was developed to provide guidance on the diagnosis and management of drug hypersensitivity reactions. It was last updated...
drug allergypracticeparameterupdatesincorporate